The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Autologous dendritic cell vaccine (ADCV) in combination with plasmapheresis (PP) and cyclophosphamide (Cy) in patients with disseminated melanoma: A phase II study.
Vladimir Moiseyenko
No relevant relationships to disclose
Irina Alexandrovma Baldueva
No relevant relationships to disclose
Alexey Viktorovich Novik
No relevant relationships to disclose
Tatyana Leonidovna Nehaeva
No relevant relationships to disclose
Anna Borisovna Danilova
No relevant relationships to disclose
Alexey Olegovich Danilov
No relevant relationships to disclose
Tatyana Petrova
No relevant relationships to disclose
Svetlana Protsenko
No relevant relationships to disclose
Tatyana Michailichenko
No relevant relationships to disclose
Anna Igorevna Semenova
No relevant relationships to disclose
Gulfiya Midhatovna Teletaeva
No relevant relationships to disclose